A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection-Reference-Cited by-同舟云学术

A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection

Published:2022-08 Issue: Volume:44 Page:102584
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Olivera-Ugarte Santa-Mariela,Bolduc Marilène,Laliberté-Gagné Marie-Ève,Blanchette Léa-Jeanne,Garneau Caroline,Fillion Maude,Savard Pierre,Dubuc Isabelle,Flamand Louis,Farnòs Omar,Xu Xingge,Kamen Amine,Gilbert Mégan,Rabezanahary Henintsoa,Scarrone Martina,Couture Christian,Baz Mariana,Leclerc Denis

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Reference73 articles.

1. Global burden of COVID-19: situational analyis and review;Gebru;Hum Antibodies,2021

2. Progress and pitfalls in the quest for effective SARS-CoV-2 (COVID-19) vaccines;Flanagan;Front Immunol,2020

3. Nano-carriers of COVID-19 vaccines: the main pillars of efficacy;Constantin;Nanomedicine (Lond),2021

4. Next-generation vaccines: nanoparticle-mediated DNA and mRNA delivery;Ho;Adv Healthc Mater,2021

5. Adenoviral vector-based platforms for developing effective vaccines to combat respiratory viral infections;Elkashif;Clin Transl Immunol,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for developing self-assembled nanoparticle vaccines against SARS-CoV-2 infection;Frontiers in Immunology;2024-09-11

2. Nanovaccines for Veterinary Applications;Nanocarrier Vaccines;2024-02-16

3. A rapid procedure to generate stably transfected HEK293 suspension cells for recombinant protein manufacturing: Yield improvements, bioreactor production and downstream processing;Protein Expression and Purification;2023-10

4. Plant Viruses as Adjuvants for Next-Generation Vaccines and Immunotherapy;Vaccines;2023-08-16

5. Mosaic receptor binding domain nanoparticles: towards fourth-generation vaccination;Nanomedicine;2023-08